HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Quinoxaline-2-carbaldehyde → 2-({4-[2-(4-Tert-butylphenyl)-1,3-benzothiazol-7-yl]piperazin-1-yl}methyl) quinoxaline

HRID 491430
Print

Reaction equation

HRID 491430 reaction equation
[C:1]([C:5]1[CH:10]=[CH:9][C:8]([C:11]2[S:12][C:13]3[C:19]([N:20]4[CH2:25][CH2:24][NH:23][CH2:22][CH2:21]4)=[CH:18][CH:17]=[CH:16][C:14]=3[N:15]=2)=[CH:7][CH:6]=1)([CH3:4])([CH3:3])[CH3:2].[N:26]1[C:35]2[C:30](=[CH:31][CH:32]=[CH:33][CH:34]=2)[N:29]=[CH:28][C:27]=1[CH:36]=O.C(O[BH-](OC(=O)C)OC(=O)C)(=O)C.[Na+]>ClCCCl.C(O)(=O)C>[C:1]([C:5]1[CH:6]=[CH:7][C:8]([C:11]2[S:12][C:13]3[C:19]([N:20]4[CH2:25][CH2:24][N:23]([CH2:36][C:27]5[CH:28]=[N:29][C:30]6[C:35](=[CH:34][CH:33]=[CH:32][CH:31]=6)[N:26]=5)[CH2:22][CH2:21]4)=[CH:18][CH:17]=[CH:16][C:14]=3[N:15]=2)=[CH:9][CH:10]=1)([CH3:4])([CH3:2])[CH3:3]
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

6

Reactant 3

HCID 594088Quinoxaline-2-carbaldehydeHCID 5049666Sodium triacetoxyborohydrideHCID 576782972-(4-Tert-butylphenyl)-7-piperazin-1-yl-1,3-benzothiazole

Product 1

HCID 119982772-({4-[2-(4-Tert-butylphenyl)-1,3-benzothiazol-7-yl]piperazin-1-yl}methyl) quinoxalineYield 55%

Reagents, catalysts & solvents 2

HCID 176
Acetic Acid
Catalyst
HCID 111,2-DichloroethaneSolvent

Procedure

The piperazine template (0.075 g, 0.213 mmol) of Example 24 was dissolved in 1,2-dichloroethane (3 mL) and treated with quinoxaline-2-carbaldehyde (0.044 g, 0.277 mmol) and glacial acetic acid (2 drops). Sodium triacetoxyborohydride (0.090 g, 0.426 mmol) was added, and the mixture was stirred at room temperature until the reaction was complete by LCMS analysis. The solvent was removed under reduced pressure, and the resulting residue was purified by RP-HPLC to yield the free base (0.0578 g, 55% yield). MS (ESI) m/z 494.

Workup

  1. customThe solvent was removed under reduced pressure
  2. customthe resulting residue was purified by RP-HPLC

Sources & evidence

ORD record
ord-e55cb59139414209ac3587dd58e64a21
Source dataset
uspto-grants-2009_05
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US07531542B2

Reaction notes

On this pageParticipantsProcedureWorkupSources & evidenceReaction notes